Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: A randomized, double-blind, placebo-controlled extension trial

J. D. Adachi, K. G. Saag, P. D. Delmas, U. A. Liberman, R. D. Emkey, E. Seeman, Nancy E Lane, J. M. Kaufman, P. E E Poubelle, F. Hawkins, R. Correa-Rotter, C. J. Menkes, J. A. Rodriguez-Portales, T. J. Schnitzer, J. A. Block, J. Wing, H. H. McLlwain, R. Westhovens, J. Brown, J. A. Melo-GomesB. L. Gruber, M. J. Yanover, M. O R Leite, K. G. Siminoski, M. C. Nevitt, J. T. Sharp, M. P. Malice, T. Dumortier, M. Czachur, W. Carofano, A. Daifotis

Research output: Contribution to journalArticlepeer-review

443 Scopus citations

Fingerprint

Dive into the research topics of 'Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: A randomized, double-blind, placebo-controlled extension trial'. Together they form a unique fingerprint.

Medicine & Life Sciences